Emtricitabine/Tenofovir disoproxil Krka
Active substance: emtricitabine, tenofovir disoproxil succinate
emtricitabine, tenofovir disoproxil succinate
Centralised EU authorisationActive
Marketing holder: KRKA, d.d., Novo mesto
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 42 |
|
| US 74 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-391f-7c93-9bdd-0023c50ab2b9,01a120c3-4132-7e5c-8fd8-bbb023758e32,01a120c3-77d7-74bc-a372-359293232bf8,01a120c4-b6a7-7d72-b9fe-7e0835d9e490,01a120c5-afdb-7677-9bd1-82b82d2bb560;count=7 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a12090-8a65-7bc2-bf24-bc2b9d105c9b,01a12095-677b-73c2-b1d9-d6c6d9234a15,01a12099-5176-7502-aae8-1f6f74595746,01a1209b-76a9-7efb-aadd-4717facd92f1,01a1209b-76af-781a-99b0-508910a2d231;count=5 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/004215
- Registration status
- Active
- ATC code
- J05AR03
- product · EMA · EMEA/H/C/004215 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004215 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004215 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/004215 · Verified 2026-10-09